The start-up plans to expand its team in the coming months while developing its flagship product, which can test for sepsis and get results within 15 minutes.
Irish medtech Novus Diagnostics has secured €5m in equity financing to further develop its rapid detection sepsis test.
The round was led by Grimpeur Holdings, with participation from Enterprise Ireland and the European Innovation Council (EIC). This follows €2.4m in funding from the EIC in 2020, bringing the total funds raised by the former Start-Up of the Week to €7.4m.
Sepsis is the body’s extreme immune response to an infection. Failure to diagnose and treat sepsis early can lead to septic shock, organ failure and sometimes death.